{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T10:12:52Z","timestamp":1787911972711,"version":"build-2784847793"},"reference-count":49,"publisher":"Oxford University Press (OUP)","issue":"suppl_1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1093\/infdis\/jiu128","type":"journal-article","created":{"date-parts":[[2014,10,14]],"date-time":"2014-10-14T12:59:57Z","timestamp":1413291597000},"page":"S459-S464","source":"Crossref","is-referenced-by-count":63,"title":["Affordable Inactivated Poliovirus Vaccine: Strategies and Progress"],"prefix":"10.1093","volume":"210","author":[{"given":"Hiromasa","family":"Okayasu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland W.","family":"Sutter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamid S.","family":"Jafari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Takane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. Bruce","family":"Aylward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2014,11,1]]},"reference":[{"key":"key\n\t\t\t\t20170702123527_JIU128C1","article-title":"Polio this week.","author":"Global Polio Eradication Initiative"},{"key":"key\n\t\t\t\t20170702123527_JIU128C2","article-title":"Current OPV supply and outlook","author":"UNICEF supply division"},{"key":"key\n\t\t\t\t20170702123527_JIU128C3","first-page":"17","article-title":"Risk assessment: frequency and burden of VAPP, cVDPV and iVDPV. In:","author":"World Health Organization","year":"2003"},{"key":"key\n\t\t\t\t20170702123527_JIU128C4","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1146\/annurev.micro.58.030603.123625","article-title":"Vaccine-derived polioviruses and the endgame strategy for global polio eradication","volume":"59","author":"Kew","year":"2005","journal-title":"Annu Rev Microbiol"},{"key":"key\n\t\t\t\t20170702123527_JIU128C5","article-title":"Agenda item 11.2 Poliomyelitis: mechanism for management of potential risks to eradication","author":"World Health Organization"},{"key":"key\n\t\t\t\t20170702123527_JIU128C6","article-title":"Strategic plan 2010\u20132012","author":"Global Polio Eradication Initiative"},{"key":"key\n\t\t\t\t20170702123527_JIU128C7","article-title":"Circulating vaccine-derived poliovirus","author":"Global Polio Eradication Initiative"},{"key":"key\n\t\t\t\t20170702123527_JIU128C8","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1056\/NEJMoa0909383","article-title":"Fractional doses of inactivated poliovirus vaccine in Oman","volume":"362","author":"Mohammed","year":"2010","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170702123527_JIU128C9","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1086\/651611","article-title":"Randomized controlled clinical trial of fractional doses of inactivated poliovirus vaccine administered intradermally by needle-free device in Cuba","volume":"201","author":"Resik","year":"2010","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20170702123527_JIU128C10","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1016\/S0140-6736(10)61230-5","article-title":"Immunogenicity of bivalent types 1 and 3 oral poliovirus vaccine: a randomised, double-blind, controlled trial","volume":"376","author":"Sutter","year":"2010","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20170702123527_JIU128C11","first-page":"222","article-title":"Apparent global interruption of wild poliovirus type 2 transmission","volume":"50","author":"Centers for Disease Control and Prevention (CDC)","year":"2001","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key\n\t\t\t\t20170702123527_JIU128C12","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1056\/NEJMp1104329","article-title":"The polio endgame","volume":"364","author":"Aylward","year":"2011","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170702123527_JIU128C13","article-title":"Current IPV supply, recent tender results and outlook for the future","author":"UNICEF supply division"},{"key":"key\n\t\t\t\t20170702123527_JIU128C14","article-title":"Agenda item 13.10. Poliomyelitis: intensification of the global eradication initiative","author":"World Health Organization","year":"2012"},{"key":"key\n\t\t\t\t20170702123527_JIU128C15","first-page":"1","article-title":"Meeting of the Strategic Advisory Group of Experts on immunization, November 2013 -- conclusions and recommendations","volume":"89","year":"2014","journal-title":"Wkly Epidemiol Rec"},{"key":"key\n\t\t\t\t20170702123527_JIU128C16","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1056\/NEJMc1009551","article-title":"Poliovirus Vaccine and Vaccine-Derived Polioviruses","volume":"363","year":"2010","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170702123527_JIU128C17","first-page":"213","article-title":"Polio vaccines and polio immunization in the pre-eradication era: WHO position paper","volume":"85","year":"2010","journal-title":"Wkly Epidemiol Rec"},{"key":"key\n\t\t\t\t20170702123527_JIU128C18","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.coviro.2013.05.007","article-title":"Poliovirus vaccination options for achieving eradication and securing the endgame","volume":"3","author":"Est\u00edvariz","year":"2013","journal-title":"Curr Opin Virol"},{"key":"key\n\t\t\t\t20170702123527_JIU128C19","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1056\/NEJMoa1202541","article-title":"Priming after a fractional dose of inactivated poliovirus vaccine","volume":"368","author":"Resik","year":"2013","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170702123527_JIU128C20","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1001\/jama.1953.13.1081","article-title":"Studies in human subjects on active immunization against poliomyelitis. I. A preliminary report of experiments in progress","volume":"151","author":"Salk","year":"1953","journal-title":"J Am Med Assoc"},{"key":"key\n\t\t\t\t20170702123527_JIU128C21","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1542\/peds.12.5.471","article-title":"Recent studies on immunization against poliomyelitis","volume":"12","author":"Salk","year":"1953","journal-title":"Pediatrics"},{"key":"key\n\t\t\t\t20170702123527_JIU128C22","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/0140-6736(91)90480-D","article-title":"Immune response to intradermally injected inactivated poliovirus vaccine","volume":"338","author":"Samuel","year":"1991","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20170702123527_JIU128C23","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/0264-410X(92)90039-M","article-title":"Immune response of infants to inactivated poliovirus vaccine injected intradermally","volume":"10","author":"Samuel","year":"1992","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20170702123527_JIU128C24","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/S0264-410X(97)00293-4","article-title":"Immune response of infants to fractional doses of intradermally administered inactivated poliovirus vaccine","volume":"16","author":"Nirmal","year":"1998","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20170702123527_JIU128C25","doi-asserted-by":"crossref","first-page":"e110","DOI":"10.1016\/j.ijid.2011.10.002","article-title":"Randomized controlled study of fractional doses of inactivated poliovirus vaccine administered intradermally with a needle in the Philippines","volume":"16","author":"Cadorna-Carlos","year":"2012","journal-title":"Int J Infect Dis"},{"key":"key\n\t\t\t\t20170702123527_JIU128C26","first-page":"201","article-title":"Meeting of the Strategic Advisory Group of Experts on immunization, April 2012--conclusions and recommendations","volume":"87","year":"2012","journal-title":"Wkly Epidemiol Rec"},{"key":"key\n\t\t\t\t20170702123527_JIU128C27","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.vaccine.2008.10.077","article-title":"Safety and efficacy of a novel microneedle device for dose sparing intradermal influenza vaccination in healthy adults","volume":"27","author":"Van Damme","year":"2009","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20170702123527_JIU128C28","doi-asserted-by":"crossref","first-page":"2707","DOI":"10.1016\/j.vaccine.2011.12.069","article-title":"Quantitative and qualitative analysis of antibody response after dose sparing intradermal 2009 H1N1 vaccination","volume":"30","author":"Hung","year":"2012","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20170702123527_JIU128C29","doi-asserted-by":"crossref","first-page":"6427","DOI":"10.1016\/j.vaccine.2012.08.014","article-title":"Dose sparing intradermal trivalent influenza (2010\/2011) vaccination overcomes reduced immunogenicity of the 2009 H1N1 strain","volume":"30","author":"Hung","year":"2012","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20170702123527_JIU128C30","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1517\/14712598.2011.557658","article-title":"Intradermal influenza vaccine and new devices: a promising chance for vaccine improvement","volume":"11","author":"Ansaldi","year":"2011","journal-title":"Expert Opin Biol Ther"},{"key":"key\n\t\t\t\t20170702123527_JIU128C31","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1038\/nm.2182","article-title":"Dissolving polymer microneedle patches for influenza vaccination","volume":"16","author":"Sullivan","year":"2010","journal-title":"Nat Med"},{"key":"key\n\t\t\t\t20170702123527_JIU128C32","doi-asserted-by":"crossref","first-page":"3403","DOI":"10.1016\/j.vaccine.2012.09.062","article-title":"Measles vaccination using a microneedle patch","volume":"31","author":"Edens","year":"2013","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20170702123527_JIU128C33","doi-asserted-by":"crossref","first-page":"3396","DOI":"10.1016\/j.vaccine.2012.11.027","article-title":"Dose sparing and enhanced immunogenicity of inactivated rotavirus vaccine administered by skin vaccination using a microneedle patch","volume":"31","author":"Moon","year":"2013","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20170702123527_JIU128C34","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1086\/499970","article-title":"1,25-dihydroxyvitamin d3 enhances systemic and mucosal immune responses to inactivated poliovirus vaccine in mice","volume":"193","author":"Ivanov","year":"2006","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20170702123527_JIU128C35","doi-asserted-by":"crossref","first-page":"6558","DOI":"10.1016\/j.vaccine.2009.08.047","article-title":"CpG oligodeoxynucleotides are a potent adjuvant for an inactivated polio vaccine produced from Sabin strains of poliovirus","volume":"27","author":"Yang","year":"2009","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20170702123527_JIU128C36","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.vaccine.2010.11.043","article-title":"Increased potency of an inactivated trivalent polio vaccine with oil-in-water emulsions","volume":"29","author":"Baldwin","year":"2011","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20170702123527_JIU128C37","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1016\/j.vaccine.2012.12.076","article-title":"Antigen sparing with adjuvanted inactivated polio vaccine based on Sabin strains","volume":"31","author":"Westdijk","year":"2013","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20170702123527_JIU128C38","doi-asserted-by":"crossref","first-page":"7188","DOI":"10.1016\/j.vaccine.2011.05.079","article-title":"Inactivated polio vaccine development for technology transfer using attenuated Sabin poliovirus strains to shift from Salk-IPV to Sabin-IPV","volume":"29","author":"Bakker","year":"2011","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20170702123527_JIU128C39","article-title":"Sabin-IPV development, clinical trials & optimization","author":"Bakker","year":"2012"},{"key":"key\n\t\t\t\t20170702123527_JIU128C40","doi-asserted-by":"crossref","first-page":"3238","DOI":"10.1016\/j.vaccine.2010.02.010","article-title":"Alphavirus replicon-based enhancement of mucosal and systemic immunity is linked to the innate response generated by primary immunization","volume":"28","author":"Tonkin","year":"2010","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20170702123527_JIU128C41","first-page":"72","article-title":"Feasibility study of using Sabin-IPV immunization in post-eradication era in China","volume":"16","author":"Che","year":"2010","journal-title":"Zhongguo Yi Miao He Mian Yi"},{"key":"key\n\t\t\t\t20170702123527_JIU128C42","first-page":"151","article-title":"Development of inactivated poliovirus vaccine derived from Sabin strains","volume":"34","author":"Shimizu","year":"2006","journal-title":"Biol J Int Assoc Biol Stand"},{"key":"key\n\t\t\t\t20170702123527_JIU128C43","doi-asserted-by":"crossref","first-page":"57","DOI":"10.2222\/jsv.62.57","article-title":"Poliovirus vaccine","volume":"62","author":"Shimizu","year":"2012","journal-title":"Uirusu"},{"key":"key\n\t\t\t\t20170702123527_JIU128C44","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1586\/erv.11.51","article-title":"Clinical development of a novel inactivated poliomyelitis vaccine based on attenuated Sabin poliovirus strains","volume":"10","author":"Verdijk","year":"2011","journal-title":"Expert Rev Vaccines"},{"key":"key\n\t\t\t\t20170702123527_JIU128C45","article-title":"Progress toward a low COGs PER.C6 based IPV","author":"Rolli","year":"2012"},{"key":"key\n\t\t\t\t20170702123527_JIU128C46","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1086\/593310","article-title":"New generation of inactivated poliovirus vaccines for universal immunization after eradication of poliomyelitis","volume":"47","author":"Chumakov","year":"2008","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170702123527_JIU128C47","article-title":"Stable packaging cell lines for the same and efficient manufacture of vaccines against polio and other viruses","author":"Stony Brook University"},{"key":"key\n\t\t\t\t20170702123527_JIU128C48","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1517\/14728214.2012.744393","article-title":"Emerging human papillomavirus vaccines","volume":"17","author":"Ma","year":"2012","journal-title":"Expert Opin Emerg Drugs"},{"key":"key\n\t\t\t\t20170702123527_JIU128C49","article-title":"Polio eradication and endgame strategic plan 2013\u20132018","author":"Global Polio Eradication Initiative","year":"2013"}],"container-title":["The Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jid\/article-pdf\/210\/suppl_1\/S459\/18083881\/jiu128.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,19]],"date-time":"2022-04-19T23:10:05Z","timestamp":1650409805000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jid\/article-lookup\/doi\/10.1093\/infdis\/jiu128"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11]]},"references-count":49,"journal-issue":{"issue":"suppl_1","published-online":{"date-parts":[[2014,11,1]]},"published-print":{"date-parts":[[2014,11]]}},"URL":"https:\/\/doi.org\/10.1093\/infdis\/jiu128","relation":{},"ISSN":["0022-1899","1537-6613"],"issn-type":[{"value":"0022-1899","type":"print"},{"value":"1537-6613","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,11]]}}}